Wound complications after inguinal lymph node dissection for melanoma: Is ACS NSQIP adequate?

Annals of Surgical Oncology

Volumn 20, Issue 6, 2013, Pages 2049-2055

  Glarner, Carly E ^a   Greenblatt, David Y ^a   Rettammel, Robert J ^a   Neuman, Heather B ^a   Weber, Sharon M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DATA BASE; DEEP SURGICAL SITE INFECTION; DIABETES MELLITUS; FEMALE; HEALTH PROGRAM; HUMAN; INGUINAL LYMPHADENECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; REOPERATION; STANDARD; SUPERFICIAL SURGICAL SITE INFECTION; SURGICAL INFECTION; SURGICAL RISK; SURGICAL WOUND;

ADULT; AGED; DATABASES, FACTUAL; DIABETES COMPLICATIONS; FEMALE; HUMANS; INGUINAL CANAL; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SURGICAL WOUND DEHISCENCE; SURGICAL WOUND INFECTION;

EID: 84878262305     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2856-7     Document Type: Article

References (14)

1. Howlader N NA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute, 1975-2009 (Vintage 2009 Populations).
2. Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764-72.
3. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysis. Ann Surg. 1991;214(5):627-36.
4. Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg. 2003;73(5):294-9.
5. American College of Surgeons National Surgical Quality Improvement Program. Available at: http://site.acsnsqip.org. Accessed 10 Nov 2011.
6. Centers for Disease Control and Prevention. Surgical Site Infection (SSI) Event. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf. Accessed 27 Jan 2012.
7. Guggenheim MM, Hug U, Jung FJ, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247(4):687-93.
8. de Vries M, Vonkeman WG, van Ginkel RJ, et al. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32(7):785-9.
9. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87(7):892-901.
10. Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg. 1994;81(12):1771-4.
11. Beitsch P, Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg. 1992;164(5):462-5; discussion 465-6.
12. Shaw JH, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg. 1990;77(7):760-4.
13. Poos HP, Kruijff S, Bastiaannet E, et al. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol. 2009;35(8):877-83.
14. Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141(6):728-35.